Conditional knockdown of hepatic PCSK9 ameliorates high-fat diet-induced liver inflammation in mice

InstructionAccumulating evidence has shown that proprotein convertase subtilisin/kexin type 9 (PCSK9) is associated with inflammation in the vascular system. However, the roles of PCSK9 in hepatic inflammation remain unclear. Because PCSK9 is mainly expressed in the liver and modulates lipid uptake...

Full description

Saved in:
Bibliographic Details
Main Authors: Xue-Ying Zhang, Qing-Qing Lu, Yan-Jie Li, Shan-Rui Shi, Chao-Nan Ma, Miao Miao, Shou-Dong Guo
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1528250/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832548220122693632
author Xue-Ying Zhang
Qing-Qing Lu
Yan-Jie Li
Shan-Rui Shi
Chao-Nan Ma
Miao Miao
Shou-Dong Guo
author_facet Xue-Ying Zhang
Qing-Qing Lu
Yan-Jie Li
Shan-Rui Shi
Chao-Nan Ma
Miao Miao
Shou-Dong Guo
author_sort Xue-Ying Zhang
collection DOAJ
description InstructionAccumulating evidence has shown that proprotein convertase subtilisin/kexin type 9 (PCSK9) is associated with inflammation in the vascular system. However, the roles of PCSK9 in hepatic inflammation remain unclear. Because PCSK9 is mainly expressed in the liver and modulates lipid uptake through low-density lipoprotein receptor family members, the present study aimed to elucidate the effect of conditional knockdown of hepatic PCSK9 on hyperlipidemia-induced inflammation and the underlying mechanisms of action.MethodsPCSK9flox/flox mice were bred with ALB-Cre+ mice to obtain hepatic PCSK9(−/−), PCSK9(+/−), and PCSK9(+/+) mice. These mice were fed with a high-fat diet for 9 weeks to induce inflammation. The effects of conditional knockdown of hepatic PCSK9 on inflammation and the underlying mechanisms were investigated by molecular biological techniques. Moreover, the findings were verified in vitro using HepG2 cells.Results and DiscussionConditional knockdown of hepatic PCSK9 remarkably decreased plasma levels of total cholesterol and alleviated hyperlipidemia-induced liver injury. Mechanistically, conditional knockdown of hepatic PCSK9 significantly reduced the levels of pro-inflammatory factors by downregulating the expression of Toll-like receptors, mitogen-activated protein kinase (MAPK), and phosphoinositide-3 kinase/protein kinase B, which subsequently attenuated the expression of downstream molecules, namely nuclear factor kappa-B and activator protein-1. The related mechanisms were confirmed using lipid-loaded HepG2 cells together with PCSK9 siRNA, alirocumab (anti-PCSK9 antibody), and/or a p38-MAPK inhibitor. These findings confirmed that conditional knockdown of hepatic PCSK9 attenuates liver inflammation following hyperlipidemia induction by modulating multiple signaling pathways; this suggests that targeting PCSK9 knockdown/inhibition with appropriate agents is useful not only for treating hyperlipidemia but also for ameliorating hyperlipidemia-induced liver inflammation.
format Article
id doaj-art-c596a1f4d0f348a5bcaad9045452b68e
institution Kabale University
issn 1663-9812
language English
publishDate 2025-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj-art-c596a1f4d0f348a5bcaad9045452b68e2025-02-03T06:33:49ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122025-02-011610.3389/fphar.2025.15282501528250Conditional knockdown of hepatic PCSK9 ameliorates high-fat diet-induced liver inflammation in miceXue-Ying ZhangQing-Qing LuYan-Jie LiShan-Rui ShiChao-Nan MaMiao MiaoShou-Dong GuoInstructionAccumulating evidence has shown that proprotein convertase subtilisin/kexin type 9 (PCSK9) is associated with inflammation in the vascular system. However, the roles of PCSK9 in hepatic inflammation remain unclear. Because PCSK9 is mainly expressed in the liver and modulates lipid uptake through low-density lipoprotein receptor family members, the present study aimed to elucidate the effect of conditional knockdown of hepatic PCSK9 on hyperlipidemia-induced inflammation and the underlying mechanisms of action.MethodsPCSK9flox/flox mice were bred with ALB-Cre+ mice to obtain hepatic PCSK9(−/−), PCSK9(+/−), and PCSK9(+/+) mice. These mice were fed with a high-fat diet for 9 weeks to induce inflammation. The effects of conditional knockdown of hepatic PCSK9 on inflammation and the underlying mechanisms were investigated by molecular biological techniques. Moreover, the findings were verified in vitro using HepG2 cells.Results and DiscussionConditional knockdown of hepatic PCSK9 remarkably decreased plasma levels of total cholesterol and alleviated hyperlipidemia-induced liver injury. Mechanistically, conditional knockdown of hepatic PCSK9 significantly reduced the levels of pro-inflammatory factors by downregulating the expression of Toll-like receptors, mitogen-activated protein kinase (MAPK), and phosphoinositide-3 kinase/protein kinase B, which subsequently attenuated the expression of downstream molecules, namely nuclear factor kappa-B and activator protein-1. The related mechanisms were confirmed using lipid-loaded HepG2 cells together with PCSK9 siRNA, alirocumab (anti-PCSK9 antibody), and/or a p38-MAPK inhibitor. These findings confirmed that conditional knockdown of hepatic PCSK9 attenuates liver inflammation following hyperlipidemia induction by modulating multiple signaling pathways; this suggests that targeting PCSK9 knockdown/inhibition with appropriate agents is useful not only for treating hyperlipidemia but also for ameliorating hyperlipidemia-induced liver inflammation.https://www.frontiersin.org/articles/10.3389/fphar.2025.1528250/fullinflammationMAPKPCSK9 inhibitorPCSK9 siRNAToll-like receptor
spellingShingle Xue-Ying Zhang
Qing-Qing Lu
Yan-Jie Li
Shan-Rui Shi
Chao-Nan Ma
Miao Miao
Shou-Dong Guo
Conditional knockdown of hepatic PCSK9 ameliorates high-fat diet-induced liver inflammation in mice
Frontiers in Pharmacology
inflammation
MAPK
PCSK9 inhibitor
PCSK9 siRNA
Toll-like receptor
title Conditional knockdown of hepatic PCSK9 ameliorates high-fat diet-induced liver inflammation in mice
title_full Conditional knockdown of hepatic PCSK9 ameliorates high-fat diet-induced liver inflammation in mice
title_fullStr Conditional knockdown of hepatic PCSK9 ameliorates high-fat diet-induced liver inflammation in mice
title_full_unstemmed Conditional knockdown of hepatic PCSK9 ameliorates high-fat diet-induced liver inflammation in mice
title_short Conditional knockdown of hepatic PCSK9 ameliorates high-fat diet-induced liver inflammation in mice
title_sort conditional knockdown of hepatic pcsk9 ameliorates high fat diet induced liver inflammation in mice
topic inflammation
MAPK
PCSK9 inhibitor
PCSK9 siRNA
Toll-like receptor
url https://www.frontiersin.org/articles/10.3389/fphar.2025.1528250/full
work_keys_str_mv AT xueyingzhang conditionalknockdownofhepaticpcsk9ameliorateshighfatdietinducedliverinflammationinmice
AT qingqinglu conditionalknockdownofhepaticpcsk9ameliorateshighfatdietinducedliverinflammationinmice
AT yanjieli conditionalknockdownofhepaticpcsk9ameliorateshighfatdietinducedliverinflammationinmice
AT shanruishi conditionalknockdownofhepaticpcsk9ameliorateshighfatdietinducedliverinflammationinmice
AT chaonanma conditionalknockdownofhepaticpcsk9ameliorateshighfatdietinducedliverinflammationinmice
AT miaomiao conditionalknockdownofhepaticpcsk9ameliorateshighfatdietinducedliverinflammationinmice
AT shoudongguo conditionalknockdownofhepaticpcsk9ameliorateshighfatdietinducedliverinflammationinmice